Karpus Investment Management’s Jasper Therapeutics JSPR Stock Holding History

Karpus Investment Management’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-43,076	Closed	-$4.28M	–	308
2021 Q2	$4.28M	Buy	43,076 +3,092	+8%	+$307K	0.13%	147
2021 Q1	$3.96M	Buy	39,984 +31,279	+359%	+$3.18M	0.12%	141
2020 Q4	$871K	Sell	8,705 -4,400	-34%	-$438K	0.03%	181
2020 Q3	$1.3M	Sell	13,105 -160	-1%	-$16K	0.05%	150
2020 Q2	$1.33M	Hold	13,265	–	–	0.05%	142
2020 Q1	$1.27M	Buy	+13,265	New	+$1.3M	0.05%	152

Other funds holding JSPR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPARFS

Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Karpus Investment Management's JSPR Position: Q3 2021 in Review

Karpus Investment Management sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 43,076 shares — an estimated $4.28M sold.

Karpus Investment Management first reported a position in JSPR in Q1 2020 and held it in 6 quarters. The position peaked at $4.28M in Q2 2021. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.

Karpus Investment Management reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
Karpus Investment Management sold 43,076 Jasper Therapeutics shares in Q3 2021, an estimated $4.28M.
Karpus Investment Management first reported a position in Jasper Therapeutics in Q1 2020 and held it in 6 quarters.
Karpus Investment Management's Jasper Therapeutics position peaked at $4.28M in Q2 2021.
10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.

Based on Karpus Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.